Commure
Last reviewed
Jun 8, 2026
Sources
8 citations
Review status
Source-backed
Revision
v1 · 1,330 words
Improve this article
Add missing citations, update stale details, or suggest a clearer explanation.
Suggest edit
CtrlK
Last reviewed
Jun 8, 2026
Sources
8 citations
Review status
Source-backed
Revision
v1 · 1,330 words
Add missing citations, update stale details, or suggest a clearer explanation.
Commure is a United States healthcare technology company that builds an artificial intelligence operating system and a suite of AI tools for hospitals and health systems. Its products span ambient clinical documentation (an AI medical scribe), revenue cycle management (RCM), workforce safety, patient flow, and an application platform that connects fragmented clinical software. The company was incubated by the venture capital firm General Catalyst and, after a 2023 merger with the workflow-automation startup Athelas, is led by chief executive officer Tanay Tandon.[1][2]
Commure positions itself as an "arms dealer for the provider," supplying technology that helps hospitals reduce what it describes as a roughly trillion-dollar administrative burden on the American healthcare system.[3] As of mid-2025 the company reported running inside more than 130 health systems, integrating with more than 60 electronic health record (EHR) systems, and processing tens of billions of dollars in annual claims.[2] It is one of the most heavily funded companies in healthcare AI, valued at about 7 billion US dollars in 2026.[1]
Commure was founded in 2017 as a "creation company" inside General Catalyst, an approach in which the firm builds a startup internally rather than backing an outside founder. The company emerged from stealth and launched commercially in 2020. Its early thesis was to act as an operating system for healthcare, knitting together the many point solutions that hospitals run on top of their core EHR. Hemant Taneja, the chief executive of General Catalyst, is credited as a founder of Commure and serves as its executive chair.[2][4]
On October 4, 2023, Commure announced a merger with Athelas, a healthcare software startup founded by Tanay Tandon that had built revenue cycle management, workflow automation, and remote patient monitoring products. The combined company kept the Commure name and was valued at approximately 6 billion US dollars, supported by fresh capital from General Catalyst. Tanay Tandon, the Athelas co-founder and CEO, became chief executive of the merged entity, while Hemant Taneja took the role of executive chair.[5][4]
At the time of the merger, the two companies described a combined annual run rate above 100 million US dollars and a portfolio of revenue lines that included Revenue Cycle, Workflow Automation, Scribing, Patient Engagement, Remote Patient Monitoring, Mobile EHR, and Strongline, the company's hospital safety and asset-tracking product. The platform was branded CommureOS. The combined company's board included representatives of HCA Healthcare, the largest hospital operator in the United States.[5]
In July 2024, Commure agreed to acquire Augmedix, a publicly traded ambient AI documentation company, in an all-cash transaction valued at approximately 139 million US dollars, or 2.35 US dollars per share. The deal, which took Augmedix private, expanded Commure's ambient clinical documentation capabilities and combined the Commure Scribe and Augmedix Go products.[6]
Commure's offering centers on AI agents and automation layered across the administrative and clinical workflows of a hospital. Major product areas include:
| Product area | Description |
|---|---|
| Ambient AI scribe | Ambient documentation that converts a clinician-patient conversation into a structured medical note, reducing documentation time. |
| Revenue cycle management | AI automation for claims submission, coding, denials, appeals, and prior authorization. |
| Voice and back-office agents | AI agents for scheduling and administrative tasks across the revenue and operations stack. |
| Commure platform (CommureOS) | An application and integration layer connecting EHRs and third-party clinical software, sometimes described as a healthcare "super app." |
| Strongline | A staff-safety and asset-tracking system, including nurse badging and duress alerting. |
| Patient engagement and remote monitoring | Patient communication tools and remote patient monitoring inherited from Athelas. |
The company integrates with more than 60 EHR systems and serves hundreds of thousands of clinicians.[2] Commure has emphasized its ambient documentation rollout at HCA Healthcare, which it has described as the nation's largest ambient AI deployment.[2] In its 2026 funding announcement, management said proceeds would fund roughly 40 to 50 additional engineers and accelerate work on an AI-native electronic medical record platform and voice agents.[3]
Commure's financing has come substantially from General Catalyst, both as the firm that incubated the company and through later growth vehicles. Reported figures, which should be read as company and investor disclosures rather than audited results, include the following:
| Date | Event | Amount | Valuation |
|---|---|---|---|
| October 4, 2023 | Athelas merger with fresh General Catalyst capital | not disclosed | ~6 billion USD |
| June 19, 2025 | Growth financing from General Catalyst's Customer Value Fund | ~200 million USD | not a priced equity round |
| May 19, 2026 | Series E extension | ~70 million USD | ~7 billion USD |
On June 19, 2025, Commure announced approximately 200 million US dollars in growth financing from General Catalyst's Customer Value Fund (CVF). The CVF is a structure that provides late-stage companies with capital to pre-fund sales and marketing, repaid through a capped share of the revenue from the cohort of customers that capital helps acquire; it functions as growth financing rather than a traditional priced equity round. At that point Commure said its annual recurring revenue was in the hundreds of millions of dollars and had roughly doubled for three consecutive years.[2]
On May 19, 2026, Commure announced a Series E extension of approximately 70 million US dollars at a valuation of about 7 billion US dollars. Investors named in connection with the round included General Catalyst, Sequoia Capital, Morgan Stanley, and Kirkland and Ellis.[1][3] (The starting framing of this round as a single financing led by General Catalyst at a 7 billion dollar valuation is broadly accurate, but the approximately 200 million dollar CVF financing was a separate transaction announced in 2025, not part of the 2026 round.)
Commure is one of the most richly capitalized companies in healthcare AI and a prominent example of General Catalyst's strategy of building and backing health-technology businesses around a shared thesis. That strategy extends to the firm's separate ownership of a health system: General Catalyst's Health Assurance Transformation Corporation (HATCo) agreed to acquire Summa Health, a nonprofit system in the Akron and Canton, Ohio area, in a deal valued at roughly 485 million US dollars when signed and about 515 million US dollars at closing in 2025. The arrangement gives the General Catalyst ecosystem a provider environment in which portfolio technologies, potentially including Commure's, can be deployed, while also drawing scrutiny over the close ties between an investor, its portfolio companies, and an operating hospital.[7][8]
In ambient clinical documentation, Commure competes with Abridge, Ambience Healthcare, Suki, and Microsoft's Nuance DAX, several of which have secured deep integrations with the dominant EHR vendor Epic. In revenue cycle management and the broader operating-system pitch, Commure faces established health-IT incumbents and a wave of AI-native automation startups. The company differentiates itself by bundling ambient documentation, revenue cycle automation, staff safety, and patient engagement into a single platform sold to large US health systems, and by aligning its growth financing to measurable customer value rather than purely dilutive equity.[2][3]